tiprankstipranks
Canopus Biopharma Inc (CBIA)
OTHER OTC:CBIA
US Market
Holding CBIA?
Track your performance easily

Canopus Biopharma (CBIA) Stock Price & Analysis

19 Followers

CBIA Stock Chart & Stats


Options Prices

Currently, No data available
---

Ownership Overview

<0.01%100.00%
Insiders
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors

CBIA FAQ

What was Canopus Biopharma Inc’s price range in the past 12 months?
Currently, no data Available
What is Canopus Biopharma Inc’s market cap?
Currently, no data Available
When is Canopus Biopharma Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Canopus Biopharma Inc’s earnings last quarter?
Currently, no data Available
Is Canopus Biopharma Inc overvalued?
According to Wall Street analysts Canopus Biopharma Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
    Does Canopus Biopharma Inc pay dividends?
    Canopus Biopharma Inc does not currently pay dividends.
    What is Canopus Biopharma Inc’s EPS estimate?
    Canopus Biopharma Inc’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Canopus Biopharma Inc have?
    Canopus Biopharma Inc has 4,550,711,000 shares outstanding.
      What happened to Canopus Biopharma Inc’s price movement after its last earnings report?
      Currently, no data Available
      Which hedge fund is a major shareholder of Canopus Biopharma Inc?
      Currently, no hedge funds are holding shares in CBIA
      ---

      Canopus Biopharma Stock Smart Score

      10
      Unlock Smart Score
      1
      2
      3
      4
      5
      6
      7
      8
      9
      10

      Company Description

      Canopus Biopharma Inc

      Canopus Biopharma, Inc. develops pharmaceuticals in the areas of antiviral, radiation protection, cancer therapies, camelidae blood products and bio-barcode assay technologies. It provides pharmaceutical products and assay methods to patients suffering from infectious disease, cancer. The company was founded on April 8, 1986 and is headquartered in Santa Monica, CA.
      ---
      Similar Stocks
      Company
      Price & Change
      Follow
      Crispr Therapeutics AG
      Gilead Sciences
      Illumina
      Popular Stocks
      ---
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis